Considering Tangible Benefit for Interdependent Donors: Extending a Risk-Benefit Framework in Donor Selection
- PMID: 28425206
- PMCID: PMC6108434
- DOI: 10.1111/ajt.14319
Considering Tangible Benefit for Interdependent Donors: Extending a Risk-Benefit Framework in Donor Selection
Abstract
From its infancy, live donor transplantation has operated within a framework of acceptable risk to donors. Such a framework presumes that risks of living donation are experienced by the donor while all benefits are realized by the recipient, creating an inequitable distribution that demands minimization of donor risk. We suggest that this risk-tolerance framework ignores tangible benefits to the donor. A previously proposed framework more fully considers potential benefits to the donor and argues that risks and benefits must be balanced. We expand on this approach, and posit that donors sharing a household with and/or caring for a potential transplant patient may realize tangible benefits that are absent in a more distantly related donation (e.g. cousin, nondirected). We term these donors, whose well-being is closely tied to their recipient, "interdependent donors." A flexible risk-benefit model that combines risk assessment with benefits to interdependent donors will contribute to donor evaluation and selection that more accurately reflects what is at stake for donors. In so doing, a risk-benefit framework may allow some donors to accept greater risk in donation decisions.
Keywords: donors and donation: donor evaluation; donors and donation: living; editorial/personal viewpoint; ethics; ethics and public policy; kidney transplantation/nephrology; liver transplantation/hepatology.
© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons.
Conflict of interest statement
DISCLOSURE
The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation.
References
-
- Allen MB, Abt PL, Reese PP. What Are the Harms of Refusing to Allow Living Kidney Donation? An Expanded View of Risks and Benefits. American Journal of Transplantation. 2014;14(3):531–7. - PubMed
-
- Thiessen C, Gordon EJ, Reese PP, Kulkarni S. Development of a Donor-Centered Approach to Risk Assessment: Rebalancing Nonmaleficence and Autonomy. American Journal of Transplantation. 2015;15(9):2314–23. - PubMed
-
- Freedman B. Equipoise and the Ethics of Clinical Research. New England Journal of Medicine. 1987;317(3):141–5. - PubMed
-
- Schafer A. The Ethics of the Randomized Clinical Trial. New England Journal of Medicine. 1982;307(12):719–24. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
